Has anyone here used real-world patient data in biotech research?
I’m working on a research project where we’re looking beyond clinical trial data and trying to understand how treatments perform in real-world patients.
I’m curious how biotech teams usually approach this. Is real-world data actually useful for understanding treatment outcomes and patient populations??